IMMUNOGLOBULIN G4 (10-PROLINE) (HUMAN HEAVY CHAIN FC FRAGMENT) FUSION PROTEIN WITH TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTOR TRAF2 (HUMAN C-C DOMAIN FRAGMENT) FUSION PROTEIN WITH OX40L (HUMAN EXTRACELLULAR DOMAIN FRAGMENT), HEXAMER
Recurrent or Metastatic Solid Tumors
MedImmune LLCprotein_peptidePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 89/ 100
Competitive context
4 Active assets in the Recurrent or Metastatic Solid Tumors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ifinatamab Deruxtecan Daiichi Sankyo | Phase 2 | CCC |
Durvalumab MedImmune LLC | Phase 1 | CC |
Trastuzumab Deruxtecan Daiichi Sankyo | Phase 1 | CC |
Shr-A1811 Lixiaoling | D | |
Recombinant Anti-Epcam-Cd3 Antibody ITabMed Co., Ltd. | Phase 1 | NR |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →